← Back to all articles
PharmacologyPubMed VerifiedOpen Access

DMT and harmala alkaloids: an exploratory study of oral Acacia based formulations in healthy volunteers

Bonomo YA, Norman AF, Collins L, Castle DJ, Sarris J

Frontiers in Psychiatry (2025)

Open-label crossover
Abstract

Open-label crossover safety study in 9 healthy participants found three Acacia-derived DMT/harmala formulations had good safety profiles with no serious adverse events. Subjective effects comparable to traditional ayahuasca, supporting feasibility as clinical trial alternatives.

Participants9
Study TypeOpen-label crossover
Acaciaformulationsafetycrossoverclinical alternative
DOI: 10.3389/fpsyt.2025.1545915View on PubMed

Related Articles

Pharmacology

Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects

Aicher HD, Mueller MJ et al.

Frontiers in Psychiatry, 2024
Pharmacology

Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics

Chaves C, Dos Santos RG et al.

Frontiers in Psychiatry, 2024
Pharmacology

Harmaline and the gut-brain-immune axis: a novel therapeutic avenue in neuroinflammation and ulcerative colitis

Giri M, Arya S et al.

Inflammopharmacology, 2026
Pharmacology

Dimethyltryptamine and harmine, components of ayahuasca, prevented cocaine-induced apoptosis in SH-SY5Y human neuroblastoma cells

Salles G, de Carvalho Alves I et al.

Archives of Toxicology, 2025